Status: current, Defined. Date: 31-Jan 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4306831000168119 | romosozumab 105 mg / 1.17 mL injection, 1.17 mL pen device (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4306841000168111 | romosozumab 105 mg/1.17 mL injection, pen device | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| romosozumab 105 mg/1.17 mL injection, pen device | Is a | romosozumab | true | Inferred relationship | Some | ||
| romosozumab 105 mg/1.17 mL injection, pen device | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| romosozumab 105 mg/1.17 mL injection, pen device | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| romosozumab 105 mg/1.17 mL injection, pen device | has unit of use | pen device | true | Inferred relationship | Some | 231537217 | |
| romosozumab 105 mg/1.17 mL injection, pen device | has Australian BoSS | romosozumab | true | Inferred relationship | Some | 1824561688 | |
| romosozumab 105 mg/1.17 mL injection, pen device | has intended active ingredient | romosozumab | true | Inferred relationship | Some | 1824561688 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Evenity 105 mg/1.17 mL injection, 1.17 mL pen device | Is a | True | romosozumab 105 mg/1.17 mL injection, pen device | Inferred relationship | Some | |
| romosozumab 105 mg/1.17 mL injection, 2 x 1.17 mL pen devices | has MPUU | True | romosozumab 105 mg/1.17 mL injection, pen device | Inferred relationship | Some | 1196857547 |
Reference Sets
Medicinal product unit of use reference set
FHIR